By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Two Pills, $200,000, Can We Afford it?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Two Pills, $200,000, Can We Afford it?
FinancePolicy & LawSpecialties

Two Pills, $200,000, Can We Afford it?

Andrew Schorr
Andrew Schorr
Share
4 Min Read
Image
SHARE

Image

(Editor’s Note: This exclusive post is from one of our distinguished Advisory Board members, Andrew Schorr, author, medical journalist and cancer survivor.  Andrew is currently living in Barcelona, Spain, and reporting to us from there.)


Image

More Read

Image
Rare Form of Dwarfism Protects against Cancer, Diabetes
Are Dairy Products Good or Bad? Exhaustive Review
Obesity by Country
CMS-OMB Delaying Physician Disclosure Rule
What Healthcare Can Learn from the Financial Industry

(Editor’s Note: This exclusive post is from one of our distinguished Advisory Board members, Andrew Schorr, author, medical journalist and cancer survivor.  Andrew is currently living in Barcelona, Spain, and reporting to us from there.)


It is an “exciting” time on many levels in modern medicine, especially when it comes to the treatment of a number of cancers. So called “small molecule, targeted therapies, are being approved by the FDA and more are coming, even anointed with “breakthrough” status. For patients with conditions like chronic lymphocytic leukemia (CLL), a condition I was successfully treated for a number of years ago, there are new pills coming that are expected to greatly help even the sickest patients. Extending lives and returning many people to a high quality of life. The same has happened in other leukemias, lymphomas, myeloma, some lung cancers, some breast cancers, and advanced melanoma.  Pharnaceutical researchers have been figuring out how to turn off mutated genes that fuel cancer cell growth or prevent a cancer cell from dying. The science is very cool and the impact for patients is great.

ImageBut there’s a looming impact on our healthcare costs too. Here’s a very personal example. About a year ago I was diagnosed with a second cancer, myelofibrosis or early scarring in my bone marrow. Maybe it came from my earlier leukemia, maybe from the chemo I had years ago. Maybe not. No one knows. But the good news is there is a breakthrough new class of medicines that reverses the bad symptoms, like enlarged spleen, and the first approved medicine, a twice daily pill, allows me to lead a very full life. No symptoms and new evidence, in a just released study, of extended survival. What’s the downside? The cost is $7,700 a month. Thank God I have insurance that pays for it!

 
Now there’s more. Doctor and scientists want to kill as many cancer cells as possible to cure diseases like mine or help us live longer. Researchers thing by combining two or more new medicines they’ll get the job done more effectively. So maybe $7,700 a month + $7,700 a month for four little white pills a day. It’s exhilarating to think, as we age and are more likely to develop cancer, a few pills can send us on our way back to the golf course or bridge table. But how in the world will we afford this?
 
The drug companies are in a great position right now. Develop pills and make cancer chronic. Get paid back a lot for your drug development and then, for a few years, make boatloads of money. Believe me, I am really thankful for the drug development. I am just hoping smarter people than I am – maybe like you, dear reader – can tell us how all this will work out.
 
Wishing YOU the best of health and that those little white pills are there for you, if and when you need them!
 
Andrew Schorr, Barcelona

image: drugcosts/shutterstock
TAGGED:cancerdrug costspharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

Life Expectancy Inequality

June 30, 2011
New Insights into Bundled Payments
BusinessFinanceHospital Administration

4 Questions to Ask About Bundled Payments

January 31, 2015
Health care

8 Tips to Pass Nicotine Test When Getting a Life Insurance

November 30, 2018

Vermont Moves Closer to Single Payer Delivery

March 25, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?